Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenues $ 66,337,000 $ 42,333,000
Cost of sales 49,237,000 35,034,000
Gross profit 17,100,000 7,299,000
Operating expenses:    
Selling and administrative 17,620,000 15,515,000
Research and development 4,890,000 7,141,000
Total operating expenses 22,510,000 22,656,000
Operating loss (5,410,000) (15,357,000)
Other income (expense):    
Other income 8,000
Interest expense (1,339,000) (252,000)
Net loss $ (6,741,000) $ (15,609,000)
Net loss per share - basic $ (0.42) $ (1.01)
Net loss per share - diluted $ (0.42) $ (1.01)
Weighted average number of common shares outstanding - basic 16,055,256 15,439,530
Weighted average number of common shares outstanding - diluted 16,055,256 15,439,530